Metformin Aurobindo

Metformin, the active ingredient in Metformin Aurobindo, is a Biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus by improving blood glucose control in adult patients.

GNH USA supplies Metformin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is a biguanide antidiabetic that acts on glucose metabolism. - Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial glucose levels. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes when combined with lifestyle measures. - Polycystic ovary syndrome (PCOS): reduces insulin resistance and may improve menstrual regularity and ovulation.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Vitamin B12 deficiency: may develop with long‑term therapy. - Pancreatitis: inflammation of the pancreas.

Metformin requires careful monitoring and patient education. - Renal function assessment: avoid use in severe renal impairment. - Hepatic function monitoring: use cautiously in liver disease. - Lactic acidosis risk: discontinue before radiographic studies using contrast agents. - Pregnancy considerations: evaluate risk‑benefit; generally avoided unless clearly needed. - Vitamin B12 monitoring: periodic testing recommended for long‑term users. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several drug classes, affecting its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure and lactic acidosis. - Cimetidine: may increase metformin plasma concentrations. - Alcohol excess: raises risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and electrolytes.